A diabetes drug medical insurance negotiations successfulconfidential price exposure?

For each drug specific price reduction, the National Health Insurance Bureau allows enterprises to apply for price confidentiality, as a patient to obtain the lowest possible price, but not all enterprises have applied for price confidentiality, from the data published by the Health Insurance Bureau, this time there are 50 drugs open payment standards, 47 enterprises apply for price confidentiality, among them, the successful negotiations in Hangzhou Central and American East China Pharmaceutical Co., Ltd(referred to as Hangzhou China-China East China, is a wholly owned subsidiary of listed companies East China Pharmaceutical) produced a cabo on sugar chewing tablets (50 mg of commodity card card named as a fair price)however, a few days ago, Yunnan Province drug centralized procurement platform issued a number of drug-related changes to the public, according to the public ity, Hangzhou Central and American East China applied for Acapo sugar chewing tablets to reduce prices, from 2.6877 yuan / tablet to 1.1 yuan / piece (in June this year, Hangzhou Central and East China in Heilongjiang also offered to take the initiative to take the initiative Price reduction application, from 80.5 yuan / box to 43.46 yuan / box, equivalent to 1.45 yuan / piece), which also means that the price of a box of Acapo sugar chewing tablets from the original 80.63 yuan to 33 yuan, a decrease of 59.11%apply for a price cut at this time, either in terms of the price reduction (similar to the average price reduction for negotiated drugs) or the time node, it is easy to associate with the latest standard price for medicsit is understood that Acapo sugar is alpha-glycoside enzyme inhibitor saccharides, is the first oral sugar-lowering products, it can competitively inhibit glucose solutionase, inhibit the breakdown of starch into glucose, thereby reducing the absorption of glucose in the intestines, reduce high blood sugar after meals, and good safety, because the main food of the Chinese people to starch content of rice and pasta-based Coupled with the active marketing of Bayer, the original research manufacturer, Acapo sugar has been widely used in China, according to the 2017 version of the "China's 2017 Diabetes Prevention guide", Acapo sugar was included in the first-line drug use of type 2 diabetes, and has been included in the 2017 version of the national health insurance directory (Class A) and the 2018 version of the national base drug directoryat present, from the market pattern of Acapo sugar, because its raw materials need to be obtained through fermentation, high requirements for fermentation bacteria, high production costs, so the competition threshold is high, the main domestic manufacturers of tablets are mainly Bayer (Baytang) and Hangzhou Central and Central China East China, the capsule dosage form is mainly by Sichuan Green Leaf Pharmaceutical (Beshi) exclusive production, in addition, so far, Ishiguro, Chijin Xiangjiang, Zhejiang Haizheng, the color acacotest has been completedHangzhou, China and the East China Akapo sugar tablets as the first imitation, but also the first through the consistency evaluation of the enterprise, in recent years, the product growth rate has been higher than the original research products, market share gap is gradually narrowing, to 50mg specifications, for example, in the first quarter of 2018 Baitang provinces and cities of the average bid price of about 2.09 yuan, while Hangzhou Central and Central China's Kaboping is only 1.46 yuan / piece, 30% lower than the original research Data, Kaboping in the country's key hospitals market share increased from 15.8% in 2012 to 29.1% in the first quarter of 2018, the market share of the original research manufacturer Bayer gradually eroded, import substitution trend is obvious, according to data released by East China Pharmaceuticals, Kaboping sales in 2017 exceeded 2 billion yuan, 2018 sales of 2.535 billion yuan, the growth rate reached 40%this time Caboping through the way to enter the national health insurance catalog, the price reduction also gave enough sincerity, or will usher in a new round of market volume, bai-sugar will also face its greater market impact.